Stay updated with breaking news from Nasdaq Trml. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) traded down 7.8% during trading on Tuesday . The stock traded as low as $38.61 and last traded at $39.33. 64,967 shares were traded during mid-day trading, a decline of 73% from the average session volume of 238,561 shares. The stock had previously closed at […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s stock price rose 3.5% during mid-day trading on Tuesday . The stock traded as high as $38.29 and last traded at $37.80. Approximately 11,465 shares traded hands during trading, a decline of 95% from the average daily volume of 211,499 shares. The stock had previously closed at […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $36.01, but opened at $37.60. Tourmaline Bio shares last traded at $37.47, with a volume of 329,462 shares traded. Wall Street Analysts Forecast Growth TRML has been the subject of a […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $35.37 and last traded at $35.30, with a volume of 16661 shares changing hands. The stock had previously closed at $34.57. Wall Street Analysts Forecast Growth A number of brokerages […]